Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Medical Devices

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.

TSX:SVA - Post by User

Sernova Corp

Bullboard Posts

Comment by Redbaron2211on Nov 23, 2020 10:02pm

129 Views

Post# 31958122

RE:RE:RE:RE:RE:Sernova Mgmt (or lack thereof)

Elgin it's my belief that 5 patients with cpeptide is significant enough to derisk this for either a collaboration or buy out. With the long road and fatigue the market has endured it now says prove it but with validation its a quick re-rate. If Philip is concerned about a low ball offer he may enact a share holders rights plan. not all offers are presented to share holders. I can think of a few examples including a lithium junior I'm invested in that had a low ball offer from Tesla that was turned down with no mention to share holders. Where there is smoke there is fire and I believe the blaze will be much bigger then 40c.

Bullboard Posts

NervGen Pharma: Proof that NVG-291 works?